3billion published an interview with Sookjin Lee and Chad (ChangDeok) Ji discussing Rare Disease Architecture.

Public source

Publisher name

Public post

𝐖𝐡𝐚𝐭 𝐝𝐨𝐞𝐬 𝐢𝐭 𝐭𝐚𝐤𝐞 𝐭𝐨 𝐬𝐡𝐨𝐫𝐭𝐞𝐧 𝐭𝐡𝐞 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐣𝐨𝐮𝐫𝐧𝐞𝐲 𝐟𝐨𝐫 𝐫𝐚𝐫𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬? Sometimes, the answer goe…

Log in to read the full post

Company

3billion

Your One Answer Genetic testing for rare diseases made more efficient and more accessible

Industry
Biotechnology Research
Location
Gangnam-gu, KR
Company size
51–200 employees

About 3billion

𝗘𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗢𝗱𝘆𝘀𝘀𝗲𝘆 𝘄𝗶𝘁𝗵 𝗔𝗜-𝗽𝗼𝘄𝗲𝗿𝗲𝗱 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀. 3billion is dedicated to making rare disease diagnosis faster, more accurate, and accessible for patients everywhere. We provide AI-driven genetic testing covering all rare diseases, helping physicians deliver answers with confidence. Through our unique daily reanalysis system, patients continue to receive new diagnoses without additional cost. 80,000+ patients in 80+ countries have already been tested, in collaboration with 800+ medical institutions worldwide. In 2024, 3billion was listed on KOSDAQ, a recognition of our leading technology and global growth. Our mission is simple yet powerful: to ensure that every rare disease patient has a chance to receive an answer. 🔗 Visit us: https://3billion.io 📩 For inquiries: support@3billion.io

See more

Latest activity

6 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.